1. Home
  2. BRAI vs FTH Comparison

BRAI vs FTH Comparison

Compare BRAI & FTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Braiin Limited Common Stock

BRAI

Braiin Limited Common Stock

HOLD

Current Price

$4.58

Market Cap

929.5M

Sector

N/A

ML Signal

HOLD

Logo Faeth Therapeutics Inc. Common Stock

FTH

Faeth Therapeutics Inc. Common Stock

HOLD

Current Price

$23.25

Market Cap

835.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BRAI
FTH
Founded
2022
1999
Country
Australia
United States
Employees
800
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
929.5M
835.7M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
BRAI
FTH
Price
$4.58
$23.25
Analyst Decision
Strong Buy
Analyst Count
0
14
Target Price
N/A
★ $56.67
AVG Volume (30 Days)
22.0K
★ 393.8K
Earning Date
11-14-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$30.00
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.22
$17.50
52 Week High
$32.32
$42.14

Technical Indicators

Market Signals
Indicator
BRAI
FTH
Relative Strength Index (RSI) 37.04 30.01
Support Level N/A N/A
Resistance Level $5.87 $31.37
Average True Range (ATR) 0.41 2.38
MACD -0.08 -0.65
Stochastic Oscillator 29.13 0.64

Price Performance

Historical Comparison
BRAI
FTH

About BRAI Braiin Limited Common Stock

Braiin Ltd is an Australian technology company leveraging proprietary intellectual property and patented artificial intelligence/machine learning (AI/ML) technologies to deliver actionable insights across the verticals: Agriculture, Property Technology, and Customer Experience as a Service (CXaaS). The company's platforms are designed to address inefficiencies and drive data-backed decision-making across traditionally analog sectors. It prominently focuses on the agriculture technology sector, where it has successfully deployed its AI-powered solutions across multiple implementations. It provides end-to-end solutions to improve farming productivity using IoTs, Wireless Connectivity, Robotics, Software and AI/ML.

About FTH Faeth Therapeutics Inc. Common Stock

Faeth Therapeutics Inc is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. The company's principal program is PIKTOR, an investigational all-oral combination of serabelisib and sapanisertib in development for endometrial and breast cancer.

Share on Social Networks: